The ubiquitin-activating enzyme E1 as a novel therapeutic target for the treatment of restenosis

UBA1 inhibition effectively suppresses neointimal thickening through its anti-proliferative and anti-inflammatory effects. Our results provide further evidence that the ubiquitin-proteasome system is a potential new target for the prevention of vascular restenosis.